Medrio

medrio.com · San Francisco, United States of America

Medrio provides cloud-based electronic data capture (EDC) and eClinical software used to design, run, and manage clinical trials for biopharma, medical device, and contract research organizations, with a focus on decentralized and hybrid studies. Its platform supports study build, data collection, eConsent, and patient engagement, and it generates revenue through subscription licensing and related professional services.

Revenue
$50M - $250M
Employees
201 - 1,000
Founded
2005
Headquarters
San Francisco, United States of America

Medrio customers on Arbolus

Total customers 28 21 current · 7 former
Reviews growth 9 new reviews since Jun 2026

Customers who reviewed Medrio

Seniority of Medrio customers

Most people who reviewed Medrio hold Director roles (57%), followed by C-Suite (32%) and Manager (11%).

  • Director 57%
  • C-Suite 32%
  • Manager 11%

Customers sample

Operations Leader Director NPS 10 Will renew
Data Leader Manager NPS 10 Will renew
Data Leader Director NPS 9

Employer names and spend open in the full report, along with the other 25 customers.

What 28 Arbolus experts think of Medrio

Overall sentiment: Positive

NPS responses range from 4 to 10, with a mean NPS in the mid-7s and a notable cluster of highly positive (9–10) responses among high-spend, long-tenured users. Renewal intent is strong in accounts with more than 1 year of implementation and significant spend, while pilot-phase and smaller users show greater uncertainty. Sentiment drivers include ease of use, regulatory compliance, and customer support, with negative feedback focused on reporting flexibility and pilot user satisfaction.

Everything 28 customers told us about Medrio.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

10 Net Promoter Score, from 28 scored reviews
  • Promoters 9
  • Passives 13
  • Detractors 6

Praised

  • Improved Reporting
  • Enterprise Upsell from Pilots
  • AI-Driven Optimization
  • Customer Support

Criticised

  • Pilot User Preference for Alternatives
  • Limited Reporting Flexibility
  • Non-Critical for Advanced Trials
  • Reliance on Rave EDC

What Medrio customers say

Customer Support

“One of Medrio’s main advantages for us has been customer support and the ease of developing studies compared to other tools.”

Strategy Leader · Health Care · 10,000+ employees · North America

User-Friendliness

“Medrio is designed to let studies be built and modified relatively quickly and easily, without needing intense programming or technical skills.”

Strategy Leader · Health Care · 10,000+ employees · North America

Purpose-Built Compliance

“Medrio offers a more complete infrastructure for clinical trials than RedCap, with strong compliance features like audit trails, data validation, and electronic signatures.”

Strategy Leader · Health Care · 10,000+ employees · North America

Renewal intent

Plan to renew 67%
  • Will renew 12
  • Undecided 5
  • Not renewing 1

Plan to renew, by seniority

  • C-Suite 88% 8 answers
  • Director 44% 9 answers
  • Manager 100% 1 answer
  • 8.8/10 Average score from customers who will renew
  • 6.4/10 Average score from undecided customers
  • 7/10 Average score from customers not renewing

Top alternatives

Most weighed by Medrio customers

Report

Nov 2026 28 + 1

For people who use Medrio

Do you use Medrio at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 28 customers of Medrio have already contributed

Takes a few minutes. Your identity stays anonymous.